Azacitidine 100 mg Injection (Azashine) – Oncology Export Supplier

Azacitidine 100 mg injection is a prescription-only oncology injectable supplied as a lyophilized powder for reconstitution. Marketed under the brand name Azashine, this product contains Azacitidine, a nucleoside metabolic inhibitor used within regulated oncology treatment frameworks. Azacitidine 100 mg injection is manufactured for hospital and institutional use and is supplied strictly for international export to licensed pharmaceutical distributors, hospitals, and cancer treatment centers. AmeriDrugs does not sell this product for retail or direct patient use.

Active Ingredient

• Azacitidine – 100 mg per vial
  Azacitidine is a pyrimidine nucleoside analogue used under approved oncology indications and administered under medical supervision.

Therapeutic Use

From an informational and regulatory perspective, Azacitidine 100 mg injection is used in approved hematological oncology treatment settings, as defined by regulatory authorities in the importing country. This information is provided solely for product identification and international trade reference. AmeriDrugs does not provide medical advice, treatment protocols, or patient-level guidance related to Azacitidine 100 mg injection.

Dosage Form

• Sterile lyophilized powder for injection

• Single-use vial

• Intended for subcutaneous or intravenous administration under professional supervision

• Preparation and administration decisions are determined exclusively by qualified healthcare professionals in accordance with local regulations

Quality & Manufacturing Standards

Azacitidine 100 mg injection (Azashine) is manufactured in GMP-compliant facilities operating under validated pharmaceutical quality management systems. Manufacturing includes sterile processing, batch-wise quality control, and stability testing to ensure identity, strength, purity, and consistency aligned with international export standards for Azacitidine 100 mg injection.

Packaging Information

• Single-use vial containing 100 mg lyophilized azacitidine

• Secure pharmaceutical-grade vial with rubber stopper and flip-off seal

• Export-grade secondary packaging for international transport

• Labeling compliant with prescription injectable oncology medicine regulations

Target Buyers

This product is intended exclusively for supply to:

• Licensed pharmaceutical importers and distributors

• Hospitals and oncology treatment centers

• Government and private cancer care institutions

• Authorized healthcare procurement agencies

It is not intended for retail pharmacies, online consumer sales, or direct patient distribution.

Regulatory & Compliance Note

Azacitidine 100 mg injection (Azashine) is a prescription-only oncology injectable. Importation, storage, distribution, and use must comply with the pharmaceutical laws, injectable drug regulations, and oncology approvals of the destination country. Buyers are responsible for ensuring regulatory compliance within their jurisdiction. AmeriDrugs operates solely as an export-focused pharmaceutical supplier and does not promote Azacitidine 100 mg injection for self-medication or non-regulated use.